1Chobanian AV,Bakris GL,Black HR,et al.The seventh report of the joint national committee on prevention,detection,evaluation,and treatment of high blood pressure:the JNC 7 report[ J ].JAMA,2003,289(19):2560 -2572.
2Peterson JC,Adler S,Burkart JM,et al.Blood pressure control,proteinuria,and the progression of renal disease.The modification of diet in renal disease study[J].Ann Intern Med,1995,123(10):754 -762.
3Jafar TH,Stark PC,Schmid CH,et al.Progression of chronic kidney disease:the role of blood pressure control,proteinuria,and angiotensin-converting enzyme inhibition:a patient-level meta-analysis[ J ].Ann Intern Med,2003,139 (4):244-252.
4Bakris GL,Weir MR,Secic M,et al.Differential effects of calcium antagonist subclasses on markers of nephropathy progression[ J ].Kidney Int,2004,65 (6):1991-2002.
5Locatelli F,Vecchio LD,D'Amico M,et al.Is it the agent or the blood pressure level that matters for renal protection in chronic nephropathies?[ J].J Am Soc Nephrol,2002,13 (S3):196-201.
6Ruggenenti P,Perna A,Remuzzi G; GISEN Group Investigators.Retarding progression of chronic renal disease:the neglected issue of residual proteinuria[ J ].Kidney Int,2003,63 (6):2254 -2261.
7Forman JP,Brenner BM."Hypertension" and "microalbuminuria":the bell tolls for thee[ J ].Kidney Int,2006,69 (1):22 -28.
8Brenner BM,Cooper ME,de Zeeuw D,et al.Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy[ J].N Engl J Med,2001,345 (12):861 -869.
9Nakao N,Yoshimura A,Morita H,et al.Combination treatment of angiotensin-Ⅱ receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease(COOPERATE):a randomised controlled trial[ J ].Lancet,2003,361 (9352):117-124.
10Remuzzi A,Gagliardini E,Sangalli F,et al.ACE inhibition reduces glomerulosclerosis and regenerates glomerular tissue in a model of progressive renal disease[ J ].Kidney Int,2006,69(7):1124-1130.
